Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Rectal Neoplasms × Ascorbic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 8 Multiple Myeloma 5 Prostatic Neoplasms 3 Neoplasms, Plasma Cell 3 Leukemia, Myeloid, Acute 3 Sarcoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Diseases 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Myeloproliferative Disorders 1 Mucositis 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphoid 1 Inflammation 1

Interventions

Oxaliplatin 130 Fluorouracil 123 Capecitabine 103 Leucovorin 97 Irinotecan 75 Radiotherapy 62 Bevacizumab 57 Cetuximab 40 Folfox protocol 25 Surgical Procedures, Operative 22 Drug Therapy 21 Radiation 18 Panitumumab 17 XELOX 16 Chemotherapy, Adjuvant 15 Neoadjuvant Therapy 14 Chemoradiotherapy 13 Radiotherapy, Intensity-Modulated 12 Floxuridine 9 regorafenib 8 Nivolumab 8 raltitrexed 7 IFL protocol 7 Celecoxib 7 trifluridine tipiracil drug combination 6 sintilimab 6 aflibercept 6 Trastuzumab 6 Melphalan 6 Magnetic Resonance Spectroscopy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04801511 2021-03-17

CORT

Zhongnan Hospital

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡